Home/CoRegen/Shawn Tomasello

ST

Shawn Tomasello

Chief Executive Officer

Therapeutic Areas

Oncology Solid Tumors

CoRegen Pipeline

Drug	Indication	Phase
Engineered Treg Cell Therapy (SRC knockout)	Solid Tumors	Pre-clinical

Leadership Team at CoRegen

Executive Chairman & President

Chairman of the Board

Bert W. O'Malley, MD

Inventor & Principal Scientist

View full CoRegen profile